Search results
- /en/media/14896
This notice was published on May 26, 2023.
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
- /en/media/12936
- /en/media/16111
- /en/media/14956
This notice was published on June 8, 2023.
- Prazosin hydrochloride, capsules, 0.5 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
- /en/media/14641
This notice was published on April 5, 2023.
- /en/about-us/how-file-access-information-request
You have different ways of obtaining information (online, telephone, in writing) about the health insurance plan and the Public Prescription Drug Insurance Plan, among others.
- /en/about-us/control-measures
RAMQ applies legal and control measures in order to fulfil its mission toward citizens and health professionals.
- /en/media/14646
- /en/media/3221
Coming into effect on November 10, 2017.
- /en/media/11347
This notice was published on March 25, 2021.
Sodium phosphate monobasic and dibasic replace:
- Fleet
- Lax-A NEMA